Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC).Marwan Fakih,Kanwal Pratap Singh Raghav,David Z. Chang,Johanna C. Bendell,Timothy Larson,Allen Lee Cohn,Timothy K. Huyck,David Cosgrove,Joseph A. Fiorillo,Lawrence E. Garbo,Shruthi Ravimohan,Von Potter,David D'Adamo,Neelesh Sharma,Ying A. Wang,Sabine Coppieters,Matthias Herpers,Carolina Soares Viana de Oliveira,Andrew Scott PaulsonJOURNAL OF CLINICAL ONCOLOGY（2021）引用 46|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
